|
How to Advertise on Betterchem.com…
Most advertising on this site is managed by Google Adwords. Adwords lets businesses advertise on sites
regardless of their budget. At Betterchem, your Ad campaigns can target keywords and/or the visitor's
geographical location. We do not participate in Adwords targeted campaigns at this time.
|
|
|
|
|
If you would like to target one or more of our network's 200,000 plus pages…
Purchase a banner space for a low monthly fee. Banner spaces on individual pages are available for as little as $50/month. Email sales@betterchem.com. Place "Banner Placement" in the subject line and include our page's URL (where you'd like your banner to appear) in the subject. You need to supply us with links to your banner image and URL for the target page (at your site). We will revert with price and conditions. Betterchem reserves the right to refuse ads that do not meet our editorial standards.
|
|
Free
Ad space for your pharma products.
Simply list your products and create a reciprocal link. See how.
|
| Keywords for the Ads: Lescol Capsules & Lescol XL (fluvastatin sodium) Extended release Tablets, Novartis Pharmaceutical NDA 20-261/S32 & 21-192/S4 9/6/02 9/11/02 9/6/02
Lescol XL (fluvastatin sodium) Extended release Tablets, Novartis Pharmaceutical NDA 21-192 10/6/00 10/20/00
Lescol XL (fluvastatin sodium) Extended release Tablets, Novartis Pharmaceutical NDA 21-192/S2 9/25/01 5/1/03
Lescol (fluvastatin sodium) capsules, Novartis Pharmaceutical NDA 20-261/S-018 & S-022 3/8/99 6/3/99
Lescol Supplement-018provides for a new indication, the reduction of triglycerides and ApoB in patients with primary hypercholesterolemia and mixed dyslipidemia
Lescol Supplement-022provides for a reduction in the recommended frequency of Liver Function Testing (LFT) and eliminates periodic, i.e.,
semi-annual, LFT monitoring
Lescol (fluvastatin sodium) Capsules, Novartis Pharmaceutical NDA 20-261/S-024 10/23/00 11/27/00 11/27/00
Lescol Supplement-024 as an adjunct to diet to reduce elevated total cholesterol (total-C), LDL-C, TG, and Apo B levels, and to increase HDL-C in patients with primary hypercholesterolemia and mixed dyslipidemia (Frederickson Type IIa and IIb) whose response to dietary restriction of saturated fat and cholesterol and other nonpharmacological measures has not been adequate
Lescol (fluvastatin) Capsules, Novartis Pharmaceutical NDA 20-261/S-025 12/19/00 2/20/01
Lescol (fluvastatin) Capsules, Novartis Pharmaceutical NDA 20-261/S-30
© 2008 Betterchem Corp.
|
|
